← Leaderboards
Daniel Chelsky
University Of Iowa
$1,449,276
Attributed
$3,796,785
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,796,785 · 2
By mechanism
R44$2,694,700 · 1
U01$1,102,085 · 1
Top collaborators
- Jane S Paulsen2 shared
- Robert David Steiner2 shared
- Devin Thomas Wiley2 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Beverly L Davidson$40,254,264
- Michael W Duffel$4,417,649
- Michael Chang$50,821
- Sushmita Roy$306,051
- Robert Foster Mullins$9,156,220
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainProteinsBrain TissueDiagnosisPlasmaBaseCanis FamiliarisAnalytical ToolCohortClinical CandidateClinical PracticeAssay DevelopmentAdverse EffectsCardiovascular SystemClinical TrialsChildhoodChildBiological MarkersChronicBloodBenchmarkingClinical Decision-MakingCerebrospinal FluidAnimal Model
Grant awards (4)
Development of N-tert-(butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating CLN1 Batten Disease$1,244,790
R44 · FY2025 · NS · contact PI
Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile Neuronal Ceroid Lipofuscinosis (INCL)$1,449,910
R44 · FY2022 · NS · contact PI
Integrated approach to protein biomarker identification in Huntington Disease$553,812
U01 · FY2015 · NS
Integrated approach to protein biomarker identification in Huntington Disease$548,273
U01 · FY2014 · NS